Related Experiment Videos
Nocturnal asthma: mechanisms and therapy
A Di Stefano1, M Lusuardi, A Braghiroli
1Salvatore Maugeri Foundation, IRCCS, Medical Center of Rehabilitation, Veruno (NO), Italy.
Lung
|January 1, 1997
Summary
Nocturnal asthma worsening is linked to increased airway inflammation and disease severity. Treatment focuses on anti-inflammatory drugs, including steroids, theophylline, and beta 2 agonists.
Area of Science:
- Pulmonology
- Sleep Medicine
- Pharmacology
Background:
- Nocturnal asthma symptom exacerbation affects many patients.
- Airway inflammation is implicated in nocturnal awakenings and hyperreactivity.
- Conflicting research on nocturnal asthma pathogenesis complicates understanding.
Purpose of the Study:
- To review the primary pathogenetic mechanisms of nocturnal asthma.
- To explore the pharmacologic treatments for nocturnal asthma.
- To summarize the efficacy of antileukotriene compounds in asthma management.
Main Methods:
- Literature review of studies on nocturnal asthma.
- Analysis of pathogenetic mechanisms contributing to nocturnal symptoms.
- Evaluation of current and emerging pharmacologic treatments.
Main Results:
- Nocturnal asthma may result from more severe disease, increased nocturnal inflammation, or heightened susceptibility.
- Anti-inflammatory treatments, including inhaled/oral steroids, are key.
- Combined therapies (theophylline, beta 2 agonists) and antileukotrienes show activity.
Conclusions:
- Understanding nocturnal asthma mechanisms is crucial for effective management.
- Anti-inflammatory strategies form the cornerstone of nocturnal asthma pharmacotherapy.
- Further research may refine treatment protocols for this patient group.